Literature DB >> 10736623

Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.

G D'Argenio1, G Mazzacca.   

Abstract

Short chain fatty acids (SCFAs) are the end products of anaerobic bacteria break down of carbohydrates in the large bowel. This process, namely fermentation, is an important function of the large bowel; SCFAs, mainly acetate, propionate and butyrate account for approximately 80% of the colonic anion concentration and are produced in nearly constant molar ratio 60:25:15. Among their various properties, SCFAs are readily absorbed by intestinal mucosa, are relatively high in caloric content, are metabolized by colonocytes and epatocytes, stimulate sodium and water absorption in the colon and are trophic to the intestinal mucosa. While the fermentative production of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in ruminants, the interest in the effects of SCFAs production on the human organism has been raising in the last ten years. SCFAs are of major importance in understanding the physiological function of dietary fibers and their possible role in intestinal neoplasia. SCFAs production and absorption are closely related to the nourishment of colonic mucosa, its production from dietary carbohydrates is a mechanism whereby considerable amounts of calories can be produced in short-bowel patients with remaining colonic function and kept on an appropriate dietary regimen. SCFAs enemas or oral probiotics are a new and promising treatment for ulcerative colitis. The effects have been attributed to the oxidation of SCFAs in the colonocytes and to the ability of butyrate to induce enzymes (i.e. transglutaminase) promoting mucosal restitution. Evidence is mounting regarding the effects of butyrate on various cell functions the significance of which needs further considerations. Up until now, attention has been related especially to cancer prophylaxis and treatment. This article briefly reviews the role of SCFAs, particularly butyrate, in intestinal mucosal growth and potential clinical applications in inflammatory and neoplastic processes of the large bowel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10736623     DOI: 10.1007/978-1-4757-3230-6_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  23 in total

1.  I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.

Authors:  Vicente Lorenzo-Zúñiga; Elba Llop; Cristina Suárez; Beatriz Alvarez; Luis Abreu; Jordi Espadaler; Jordi Serra
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  A novel facet to consider for the effects of butyrate on its target cells. Focus on "The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein".

Authors:  Ravinder K Gill; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

3.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

4.  Carbohydrate metabolism in Bifidobacteria.

Authors:  Karina Pokusaeva; Gerald F Fitzgerald; Douwe van Sinderen
Journal:  Genes Nutr       Date:  2011-02-16       Impact factor: 5.523

5.  Cytotoxicity of organic acids produced by anaerobic intestinal bacteria on cultured epithelial cells.

Authors:  Toshiaki Sakurazawa; Toshifumi Ohkusa
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

6.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

Authors:  L E M Willemsen; M A Koetsier; S J H van Deventer; E A F van Tol
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146.

Authors:  Shiv Prakash Verma; Ayushi Agarwal; Parimal Das
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-03-19       Impact factor: 2.416

Review 8.  Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

Authors:  Marla Dubinsky; Jonathan Braun
Journal:  Gastroenterology       Date:  2015-08-15       Impact factor: 22.682

9.  Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.

Authors:  Nadia Osman; Diya Adawi; Siv Ahrne; Bengt Jeppsson; Göran Molin
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  Genotoxic effect of bile acids on human normal and tumour colon cells and protection by dietary antioxidants and butyrate.

Authors:  Patrizia Rosignoli; Roberto Fabiani; Angelo De Bartolomeo; Raffaela Fuccelli; Maria Antonietta Pelli; Guido Morozzi
Journal:  Eur J Nutr       Date:  2008-08-06       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.